Summary
65 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 28% a year over the last 3 years.
- It holds more cash than debt: $54.8M against $46.5M.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 20 USD is left as free cash.
What to watch
- Revenue growth is slowing: 5.3% a year over the last 3 years against 22% over 5 years.
- Analysts expect revenue to fall by 8.5% this fiscal year.
- It earns only 5.4 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.2 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 22% a year over 5 years. Over the last 3 years it grew by 5.3% a year. For the next fiscal year analysts expect revenue to fall by 8.5%. Earnings per share grew by 28% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 33 USD
- Research and development 15 USD
- Sales and administration 39 USD
- Taxes and other 3.9 USD
- Net profit 9.6 USD
Net profit, industry median (Medical - Healthcare Information Services) 4.7 USD
Out of every 100 USD of revenue, 9.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.1 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.96%
- Paid out of profit
- 78%
- Raised in a row
- 2 years
You receive $0.44 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.